Taken together, this study reveals that the bone marrow-derived S100A8+ immune cells play a key role in driving BAT aging via inhibiting sympathetic innervation and that targeting S100A8+ immune cells offer a potential treatment strategy for age-related metabolic disorders. The gene discussed is S100A8; the disease is metabolic disease.